Skip to content

A Pivotal Study to Evaluate Guardian Connect CGM System Performance in China

A Pivotal Study to Evaluate Guardian Connect CGM System Performance in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022106
Enrollment
Unknown
Registered
2019-03-25
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes, Type 2 diabetes

Interventions

Single-arm:Guardian Sensor with the Guardian Connect System

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Subject is 14 - 75 years of age at time of screening. 2. Subject has a clinical diagnosis of type 1 or 2 diabetes as determined via medical record or source documentation by an individual qualified to make a medical diagnosis. 3. Subject has adequate venous access as assessed by investigator or appropriate staff. 4. Subject is willing to follow the study procedures and willing to come to study visits.

Exclusion criteria

Exclusion criteria: 1. Subject will not tolerate tape adhesive in the area of Guardian? Sensor (3) placement as assessed by qualified individual. 2. Subject has any unresolved adverse skin condition in the area of study device or device placement (e.g., psoriasis, rash, Staphylococcus infection). 3. Subject is actively participating in an investigational study (drug or device) wherein they have received treatment from an investigational study (drug or device) in the last 2 weeks. 4. Subject is female and has a positive pregnancy screening test. 5. Females of child bearing age and who are sexually active should be excluded if they are not using a form of contraception deemed reliable by investigator. 6. Subject is female and plans to become pregnant during the course of the study. 7. Subject has a hematocrit (Hct) lower than the normal reference range. 8. Subject may not be on the research staff of those performing this study.

Design outcomes

Primary

MeasureTime frame
HCT;A1C;Pregnancy Urine;demographic andbaseline characteristics;fingerstick glucose;interstitial fluid glucose levels;blood plasma glucose;

Countries

China

Contacts

Public ContactBo Jian
jian.bo@medtronic.com+86 158 1139 1874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026